ArticleResearch (Washington, D.C.)2025

tRF3a-MetCAT Promotes EGFR-Targeted Therapeutic Resistance through the TRIM21-STAT1-C5a Axis in Lung Adenocarcinoma.

Yuchen Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.